FIND Trial
Cross-source consensus on FIND Trial from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Background
Evidence quality
Other
Other
Highlighted claims
- The trial's primary aim is to assess whether a 16-session ACT-informed treatment programme is feasible for adults with DSCATT. — Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial
- Retention rate is the primary feasibility outcome. — Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial
- The feasibility study is not designed to establish treatment efficacy. — Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial
- FIND is a 32-week randomised, waitlist-controlled, parallel convergent mixed-methods feasibility and pilot trial. — Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial
- FIND is described as the first proposed clinical trial for DSCATT. — Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial
- The intervention is adjunctive to existing healthcare, except participants cannot use other psychological therapies while completing the trial therapy. — Feasibility of an adjunctive INtervention for Debilitating symptom complexes attributed to ticks (FIND): study protocol for a randomised, waitlist-controlled feasibility trial